The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (δR2*) and contrast agent (MION) dose

41Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: To determine in vivo if the susceptibility calibration factor for gradient-echo imaging (kG), which characterizes the relationship between the tissue T2* relaxation rate change (ΔR2*) and tissue contrast agent concentration, is independent of tissue type and condition: in addition, to assess the consequences of such an assumption on the use of relative cerebral blood volume (rCBV) measurements as a direct index of tumor angiogenesis. Materials and Methods: The ΔR2* was measured as a function of monocrystalline iron oxide nanoparticles (MION) contrast agent dose in a rat brain tumor (9L gliosarcoma) model, the blood volume fraction independently measured, and kG calculated and compared for the normal gray matter, normal white matter, tumor, and contralateral brain. Results: The kG was found to be the same for gray and white matter (P = 0.53), but statistically different for tumor compared to contralateral brain (P = 0.005) with kGTumor

Cite

CITATION STYLE

APA

Pathak, A. P., Rand, S. D., & Schmainda, K. M. (2003). The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (δR2*) and contrast agent (MION) dose. Journal of Magnetic Resonance Imaging, 18(4), 397–403. https://doi.org/10.1002/jmri.10371

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free